Related Experiment Video
Updated: Jul 20, 2026
Differentiation of Newborn Mouse Skin Derived Stem Cells into Germ-like Cells In vitro
Published on: July 16, 2013
De-differentiation of mouse interfollicular keratinocytes by the embryonic transcription factor Oct-4
Katie L Grinnell1, Baoli Yang, Richard L Eckert
1Department of Anatomy and Cell Biology, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA.
Abstract:
The embryonic transcription factor Oct-4 is often referred to as the master regulator of the undifferentiated state. Although its role in maintaining embryonic stem (ES) cell pluripotency is well established, its ability to directly reprogram committed somatic cells is not well defined. Using transient transfection, we tested its ability to revert mouse interfollicular epidermal basal keratinocytes to a more ES cell-like state. We found that the Oct-4-transfected keratinocytes expressed the Oct-4 target genes, Sox-2, Nanog, undifferentiated transcription factor 1 (Utf1), and Rex-1. We also noted an increase in developmental potential caused by Oct-4, with the transfected cells able to differentiate into neuronal cells when exposed to neuroectodermal differentiation medium. Control-transfected keratinocytes were unable to respond to the medium, and remained as keratinocytes. These findings suggest that Oct-4 may be the master regulator of the pluripotent state and demonstrate that differentiated somatic cells can be reverted into more developmentally potent cells through the use of a single factor. The latter finding has great implications for therapeutic cell-replacement applications using cells from easily accessible adult tissues, such as the skin.
Insights
The transcription factor Oct-4 can revert skin cells into a more potent, stem cell-like state. This single factor demonstrates potential for future therapeutic cell-replacement applications.
Area of Science:
- Stem Cell Biology
- Developmental Biology
- Cell Reprogramming
Background:
- Oct-4 is a key transcription factor maintaining embryonic stem cell pluripotency.
- Its capacity to directly reprogram differentiated somatic cells remains largely undefined.
- Understanding Oct-4's reprogramming potential is crucial for regenerative medicine.
Purpose of the Study:
- To investigate the ability of Oct-4 to revert mouse epidermal keratinocytes to a more pluripotent state.
- To determine if Oct-4 can induce ES cell-like characteristics in differentiated somatic cells.
- To explore the therapeutic implications of single-factor reprogramming.
Main Methods:
- Transient transfection of mouse interfollicular epidermal basal keratinocytes with Oct-4.
- Analysis of Oct-4 target gene expression (Sox-2, Nanog, Utf1, Rex-1).
- Assessment of cellular differentiation potential following Oct-4 expression.
Main Results:
- Oct-4 transfection induced expression of key pluripotency genes (Sox-2, Nanog, Utf1, Rex-1).
- Transfected keratinocytes gained developmental potential, differentiating into neuronal cells.
- Control keratinocytes did not exhibit pluripotency or neuronal differentiation.
Conclusions:
- Oct-4 acts as a master regulator of pluripotency, capable of reverting somatic cells.
- Single-factor reprogramming using Oct-4 is feasible for generating developmentally potent cells.
- This approach holds significant promise for cell-replacement therapies using adult skin cells.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
01:24Methods of Nuclear Reprogramming
00:57Cellular Differentiation
A zygote is a...